인공투석 시장 규모, 점유율, 동향, 예측 : 유형, 제품 및 서비스, 최종사용자, 지역별(2025-2033년)

The global dialysis market size was valued at USD 120.85 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 180.42 Billion by 2033, exhibiting a CAGR of 4.09% during 2025-2033. North America currently dominates the market in 2024, accounting to 41.0% of the market share. The major drivers of the market include the increasing prevalence of chronic kidney disease and end-stage renal disease, rising diabetes and hypertension cases, technological advancements in dialysis equipment, growing healthcare spending, expanding home dialysis solutions, favorable government policies, reimbursement initiatives, and an aging global population.

Dialysis is a crucial renal replacement therapy for individuals whose kidneys cannot function naturally. This medical procedure plays a vital role in eliminating toxins, excess water, salts, and solutes from the patient's bloodstream, effectively restoring a healthier balance. The primary objective of dialysis is to purify the blood and restore proper electrolyte levels within the body. This therapy comes in two main forms: hemodialysis and peritoneal dialysis. Hemodialysis involves the external purification of blood, a process that occurs outside the body. This technique effectively cleanses the blood of impurities, helping patients regain stability. On the other hand, peritoneal dialysis relies on the peritoneum, a lining within the abdomen, to purify the blood. By utilizing the peritoneum as a dialysis medium, this method offers an internal approach to blood cleansing. Both hemodialysis and peritoneal dialysis are instrumental in treating various kidney-related conditions. These treatments are commonly employed for addressing acute renal injuries, managing chronic kidney diseases, supporting kidney transplant procedures, or serving as a permanent solution when transplantation is not a viable option. The significance of dialysis cannot be overstated, as it significantly enhances the quality of life for individuals grappling with kidney dysfunctions. Through careful implementation and ongoing advancements in medical technology, dialysis continues to serve as a lifeline for patients needing renal support.

The global market is majorly driven by the increasing prevalence of chronic kidney diseases. In line with this, the rising aging population prone to kidney-related issues is significantly contributing to the market. Furthermore, the growing awareness about renal health and available treatment options is positively influencing the market. Apart from this, the rapid technological advancements leading to more efficient dialysis procedures are offering numerous opportunities for the market. Moreover, the heavy investments in research and development of innovative dialysis techniques are catalyzing the market. Besides, the higher incidence of diabetes, a major contributor to kidney diseases, is propelling the demand for dialysis. Additionally, the expansion of healthcare infrastructure in developing regions is providing a boost to the market. The escalating demand for home-based dialysis solutions is strengthening the market.

Dialysis Market Trends/Drivers:

Increasing lifestyle changes lead to kidney complications

The escalating trend of lifestyle changes is stimulating the market. Modern lifestyles characterized by poor dietary habits, sedentary routines, and high-stress levels contribute to a rise in kidney complications. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues has subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further driving the growth of the dialysis market. Consequently, healthcare providers, medical device manufacturers, and researchers are motivated to develop innovative solutions and strategies to address this growing demand and offer effective dialysis interventions.

Expansion of private dialysis clinics and centers

The expansion of private dialysis clinics and centers is bolstering the market. These private facilities offer several key advantages that contribute to their impact on market expansion. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization enhances patient satisfaction and outcomes, attracting a larger clientele and boosting market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.

Rising demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)

The escalating demand for Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) is fueling the market growth. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, drives market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.

Dialysis Industry Segmentation:

Breakup by Type:

• Hemodialysis
• Conventional Hemodialysis
• Short Daily Hemodialysis
• Nocturnal Hemodialysis
• Peritoneal Dialysis
• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

Hemodialysis dominates the market

Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses critical medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology has improved treatment outcomes and enhanced patient experiences.

Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions has widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.

Breakup by Product and Services:

• Services
• Equipment
• Dialysis Machines
• Water Treatment Systems
• Others
• Consumables
• Dialyzers
• Catheters
• Others
• Dialysis Drugs

Services dominates the market

The services segment is vital in driving market growth within the dialysis industry. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues.

Furthermore, the services segment includes patient education and awareness initiatives. These programs empower patients with knowledge about kidney health, available treatment options, and self-care practices. By raising awareness and promoting early intervention, these educational efforts contribute to higher demand for dialysis services. The expansion of telehealth services is also a driving factor. Remote monitoring and consultation services enable patients to access medical guidance without frequent in-person visits, making dialysis care more convenient and efficient.

Breakup by End User:

• In-center Dialysis
• Home Dialysis

In-center dialysis dominates the market

The in-center dialysis segment is a key driver of market growth within the dialysis industry. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges.

The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Patients appreciate the structured environment, professional support, and regular check-ins that in-center dialysis provides.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies.

Government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, boosting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.

Competitive Landscape:

Top companies are playing a crucial role in fostering the growth of the dialysis market through strategic initiatives and innovations. Armed with their extensive resources and expertise, these companies are driving market expansion in several ways. They invest heavily in research and development, leading to the creation of advanced dialysis technologies and treatment methods. This continuous innovation improves dialysis's efficacy, efficiency, and patient experience, enticing more individuals to opt for these treatments. Moreover, these companies collaborate with healthcare providers and institutions, ensuring widespread access to their products and services. Such partnerships facilitate the integration of cutting-edge dialysis solutions into existing healthcare ecosystems, thus expanding the market reach. Additionally, top companies often engage in awareness campaigns to educate the medical community and the general public about kidney health and available treatment options. This educational effort drives early diagnosis and intervention, increasing the demand for dialysis services. Besides, their global presence and distribution networks enable them to bring advanced dialysis solutions to regions with limited access to healthcare infrastructure. This expansion into underserved areas contributes to market growth by catering to a wider patient demographic.

The report has provided a comprehensive analysis of the competitive landscape in the dialysis market. Detailed profiles of all major companies have also been provided.

• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• DaVita Inc.
• Fresenius Medical Care AG & Co. KGaA
• JMS Co. Ltd.
• Medtronic plc
• Nikkiso Co. Ltd.
• NIPRO Corporation
• Satellite Healthcare Inc.
• Toray Industries Inc.

Key Questions Answered in This Report

• 1.How big is the dialysis market?
• 2.What is the future outlook of the dialysis market?
• 3.What are the key factors driving the dialysis market?
• 4.Which region accounts for the largest dialysis market share?
• 5.Which are the leading companies in the global dialysis market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Dialysis Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Hemodialysis
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Conventional Hemodialysis
    • 6.1.2.2 Short Daily Hemodialysis
    • 6.1.2.3 Nocturnal Hemodialysis
  • 6.1.3 Market Forecast
• 6.2 Peritoneal Dialysis
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • 6.2.2.2 Automated Peritoneal Dialysis (APD)
  • 6.2.3 Market Forecast

7 Market Breakup by Product and Services

• 7.1 Services
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Equipment
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Dialysis Machines
    • 7.2.2.2 Water Treatment Systems
    • 7.2.2.3 Others
  • 7.2.3 Market Forecast
• 7.3 Consumables
  • 7.3.1 Market Trends
  • 7.3.2 Key Segments
    • 7.3.2.1 Dialyzers
    • 7.3.2.2 Catheters
    • 7.3.2.3 Others
  • 7.3.3 Market Forecast
• 7.4 Dialysis Drugs
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 In-center Dialysis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Home Dialysis
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Asahi Kasei Corporation
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 B. Braun Melsungen AG
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 Baxter International Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Becton Dickinson and Company
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 DaVita Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Fresenius Medical Care AG & Co. KGaA
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 JMS Co. Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
  • 14.3.8 Medtronic plc
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Nikkiso Co. Ltd.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 NIPRO Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Satellite Healthcare Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Toray Industries Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis